Central Asia’s First Biothreat Research Lab to Play Threat-Reduction Role

Rachel Oswald, Global Security Newswire
Add to Briefcase
Rachel Oswald, Global Security Newswire
Aug. 9, 2013, 9:02 a.m.

SE­MEY, Kaza­kh­stan — A state-of-the-art med­ic­al re­search labor­at­ory is un­der con­struc­tion in a sub­urb of Al­maty, Kaza­kh­stan’s busi­ness cap­it­al, us­ing U.S. funds aimed at help­ing re­ori­ent former bio­lo­gic­al weapons-re­lated re­search un­der the So­viet Uni­on to peace­ful pub­lic health uses, ac­cord­ing to of­fi­cials in­volved with the pro­ject.

When it opens in 2015, the Cent­ral Ref­er­ence Labor­at­ory is ex­pec­ted to fo­cus on some of the world’s most dan­ger­ous emer­ging patho­gens with sup­port from the Nunn-Lugar Co­oper­at­ive Threat Re­duc­tion Pro­gram, draw­ing off of years of U.S. and Kaza­kh­stani joint co­oper­a­tion.

“We’re go­ing to have here the most up-to-date equip­ment,” said B.B. Atshabar, dir­ect­or of the Kaza­kh­stan Sci­entif­ic Cen­ter for Quar­ant­ine and Zo­onot­ic Dis­eases, speak­ing through a trans­lat­or to a group of U.S. journ­al­ists who vis­ited the con­struc­tion site of the new labor­at­ory on Tues­day.

Once fin­ished, the planned 87,000 square-foot labor­at­ory is slated to be the first of its kind in Cent­ral Asia to in­clude re­search areas that meet in­ter­na­tion­ally re­cog­nized Biosafety Level-3 stand­ards, which in­volve spe­cial en­gin­eer­ing, design and staff-train­ing pro­to­cols in­ten­ded to min­im­ize the risks of work­ing with po­ten­tially deadly dis­ease agents, such as an­thrax and plague. Yet more of the lab space, though, will be de­voted to Biosafety Level-2 work in­volving the study of patho­gens that pose mod­er­ate health haz­ards.

“The ul­ti­mate goal of the labor­at­ory will be its in­ter­na­tion­al ac­cred­it­a­tion,” Atshabar said. “The res­ults that will be achieved in this labor­at­ory will be open to all of the world” to util­ize, he said.

The fo­cus of work at the fu­ture fa­cil­ity will be on de­vel­op­ing im­proved dia­gnost­ic tools and coun­ter­meas­ures for patho­gens that af­fect both hu­mans and an­im­als. The labor­at­ory is also ex­pec­ted to aid neigh­bor­ing Cent­ral Asi­an states in dia­gnos­ing and con­trolling the spread of new dis­ease strains, he said.

An­thrax and plague are en­dem­ic to Kaza­kh­stan and have been pub­lic health con­cerns here for some time. Kaza­kh­stani sci­ent­ists have de­veloped con­sid­er­able ex­pert­ise in­to these patho­gens but their re­search up un­til now has taken place in loc­al labor­at­or­ies that lack the in­ter­na­tion­ally re­cog­nized BSL-3 stand­ards, ac­cord­ing to Atshabar.

Un­der the So­viet Uni­on, “there wasn’t really a no­tion of peer-re­viewed sci­ence or trans­par­ency at all. Most of what they did was very tightly clas­si­fied and they had a lot of over­lap with the mil­it­ary,” said Phil Starling, the pro­gram dir­ect­or for sci­ence en­gage­ment at CRDF Glob­al, a non­profit that works on Co­oper­at­ive Threat Re­duc­tion pro­grams in Kaza­kh­stan and else­where un­der con­tract with the U.S. gov­ern­ment. Stand­ard prac­tice at that time was for sci­ent­ists in Kaza­kh­stan identi­fy­ing new strains of plague, for ex­ample, to send samples back to Mo­scow where they would be ex­amined and stud­ied spe­cific­ally for po­ten­tial ap­plic­a­tion as bio­lo­gic­al weapons, he said.

Kaza­kh­stan be­came an in­de­pend­ent na­tion in Decem­ber 1991, fol­low­ing the dis­sol­u­tion of the So­viet Uni­on.

Through the CTR pro­gram, the United States has worked to steer Kaza­kh­stani sci­ent­ists with a back­ground in dis­eases such as plague and an­thrax to non­mil­it­ary re­search that is trans­par­ent and pub­lished un­der the prin­ciples of glob­al sci­ence, said Starling. He was in­ter­viewed by phone in the United States late last month.

“A big part of the re­ori­ent­a­tion was in­tro­du­cing [Kaza­kh­stani sci­ent­ists] to the prin­ciples of west­ern [glob­al] sci­ence,” he said. “You get fund­ing based on the rig­or of your re­search and the valid­ity of your re­search, not ne­ces­sar­ily oth­er polit­ic­al pri­or­it­ies,” he said.

An­oth­er as­pect of CTR work in Kaza­kh­stan is find­ing em­ploy­ment for those sci­ent­ists with back­grounds in bio­lo­gic­al-weapon re­lated re­search, so that they will not be temp­ted to sell their ex­pert­ise to ter­ror­ists or rogue na­tions.

“We’ve done our best to em­ploy these people who have this know­ledge. It’s one of these chal­lenges that you can­not erase this know­ledge from someone’s mind,” said Lt. Col. Charles Carlton, dir­ect­or of the U.S. De­fense Threat Re­duc­tion Of­fice in Kaza­kh­stan.

“I do think that through our ef­forts, through U.S. fund­ing, Kaza­kh­stani fund­ing, we are do­ing our best to em­ploy these people,” he said on Tues­day to re­port­ers on a trip or­gan­ized by the In­ter­na­tion­al Re­port­ing Pro­ject.

Fund­ing for the $100 mil­lion con­struc­tion of the Cent­ral Ref­er­ence Labor­at­ory is com­ing en­tirely from the United States. Once it is up and run­ning, Wash­ing­ton each year will gradu­ally re­duce the amount of funds it provides to Kaza­kh­stan to op­er­ate the sci­entif­ic fa­cil­ity, un­til the gov­ern­ment in As­tana is fully un­der­writ­ing the labor­at­ory, Carlton said.

The CRL fa­cil­ity will con­tain 5,400 square feet of BSL-3 re­search space, ac­cord­ing to Dan Erbach, the site con­struc­tion man­ager for AE­COM, the com­pany build­ing the fa­cil­ity.

The U.S. gov­ern­ment is also provid­ing ap­prox­im­ately $5.6 mil­lion to build a sep­ar­ate site fea­tur­ing BSL-3 labor­at­ory space in the vil­lage of Otar in Kaza­kh­stan’s Zhambyl­skaya re­gion. The fa­cil­ity is in­ten­ded to provide an early warn­ing of any new dis­ease out­breaks that oc­cur in the re­gion and is in­ten­ded to com­ple­ment rather than du­plic­ate the work done at the Cent­ral Ref­er­ence Labor­at­ory in Al­maty, Carlton said. The Otar fa­cil­ity is ex­pec­ted to be com­pleted next April.

What We're Following See More »
McMullin Leads in New Utah Poll
5 hours ago

Evan McMul­lin came out on top in a Emer­son Col­lege poll of Utah with 31% of the vote. Donald Trump came in second with 27%, while Hillary Clin­ton took third with 24%. Gary John­son re­ceived 5% of the vote in the sur­vey.

Quinnipiac Has Clinton Up by 7
5 hours ago

A new Quin­nipi­ac Uni­versity poll finds Hillary Clin­ton lead­ing Donald Trump by seven percentage points, 47%-40%. Trump’s “lead among men and white voters all but” van­ished from the uni­versity’s early Oc­to­ber poll. A new PPRI/Brook­ings sur­vey shows a much bigger lead, with Clinton up 51%-36%. And an IBD/TIPP poll leans the other way, showing a vir­tu­al dead heat, with Trump tak­ing 41% of the vote to Clin­ton’s 40% in a four-way match­up.

Trump: I’ll Accept the Results “If I Win”
6 hours ago
Duterte Throws His Lot in with China
9 hours ago

During a state visit to China, Philippine President Rodrigo Duterte "declared an end to his country’s strategic alignment with the United States and pledged cooperation with Beijing." Duterte told Chinese President Xi Jinping that he's "realigned myself in your ideological flow and maybe I will also go to Russia to talk to Putin and tell him that there are three of us against the world—China, Philippines, and Russia. It’s the only way.”

Hatch Considering 2018 Re-election Run
10 hours ago

Reports say that Orrin Hatch, who in 2012 declared that he would retire at the end of his term, is considering going back on that pledge to run for an eighth term. Hatch, who is the longest serving Republican in the Senate, is unlikely to make any official declaration until after this election cycle is completed.


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.